The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders

Biomarkers

Volumn 14, Issue 3, 2009, Pages 171-180

  Faber, Scott ^a   Zinn, Gregory M ^b   Kern Ii, John C ^b   Skip Kingston, H M ^b  

^a Children's Institute   (United States)

^b DUQUESNE UNIVERSITY   (United States)

Author keywords

Aspergers syndrome; Autistic disorder; Mercury; Metallothionein system dysfunction; Pervasive developmental disorder NOS; Plasma zinc serum copper ratio; Zinc deficiency

Indexed keywords

COPPER; MERCURY; METALLOTHIONEIN; ZINC; BIOLOGICAL MARKER;

ARTICLE; ASPERGER SYNDROME; AUTISM; CHILD; COPPER BLOOD LEVEL; DISEASE MARKER; FEMALE; HEAVY METAL POISONING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MERCURIALISM; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; PRESCHOOL CHILD; SCHOOL CHILD; ZINC BLOOD LEVEL; BLOOD; COHORT ANALYSIS; RETROSPECTIVE STUDY;

ASPERGER SYNDROME; AUTISTIC DISORDER; BIOLOGICAL MARKERS; CHILD; COHORT STUDIES; COPPER; HUMANS; RETROSPECTIVE STUDIES; ZINC;

EID: 66149089999     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500902783747     Document Type: Article

References (61)

1. Adams JB, Romdalvik J, Levine KE, Hu LW. 2008. Mercury in first-cut baby hair of children with autism versus typically-developing children. Toxicol Environ Chem 90:739-753.
2. Adams JB, Romdalvik J, Sadagopa Ramanujam VM, Legator MS. 2007. Mercury, lead, and zinc in baby teeth of children with autism versus controls. J Toxicol Environ Health, Part A 70:1046-1051.
3. Andrews GK. 2000. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmaco 59:95-104.
4. Arredondo M, Nunez MT. 2005. Iron and copper metabolism. Mol Aspects Med 26:313-327.
5. Aschner M. 1996. The functional significance of brain metallothioneins. FASEB J 10:1129-1136.
6. Aschner M, Syversen T, Souza DO, Rocha JBT. 2006. Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity. Exp Biol Med 231:1468-1473.
7. Ashwood ER, editor. 2004. ARUP's Guide to Pediatric Clinical Laboratory Testing: Test Interpretation, Utilization, and Age-Specific Reference Intervals, 3rd edn. Salt Lake City, UT: ARUP Laboratories.
8. Asmuss M, Mullenders Leon HF, Eker A, Hartwig A. 2000. Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair. Carcinogenesis 21:2097-2104.
9. Austin DW, Shandley K. 2008. An investigation of porphyrinuria in Australian children with autism. J Toxicol Environ Health, Part A 71:1349-1351.
10. Best K, McCoy K, Gemma S, DiSilvestro RA. 2004. Copper enzyme activities in cystic fibrosis before and after copper supplementation plus or minus Zinc. Metabolism 53:37-41.
11. Bradstreet J, Geier DA, Kartzinel JJ, Adams JB, Geier MR. 2003. A case-control study of mercury burden in children with autistic spectrum disorders. J Am Phys Surg 8:76-79.
12. Centers for Disease Control, and Prevention (CDC). 2007a. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2000. Morb Mortal Weekly Rep Surveillance Summaries 56:1-11.
13. Centers for Disease Control, and Prevention (CDC). 2007b. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, Fourteen sites, United States, 2002. Morb Mortal Weekly Rep Surveillance Summaries 56:12-28.
14. Chen B, Wen Y, Wang H, Polan ML. 2003. Differences in estrogen modulation of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-1 expression in cultured fibroblast from continent and incontinent women. Am J Obstet Gynecol 189:59-65.
15. De Bie P, Van De Sluis B, Klomp L, Wijmenga C. 2005. The many faces of the copper metabolism protein MURR1/COMMD1. J Hered 96:803-811.
16. DeSoto MC, Hitlan RT. 2007. Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set. J Child Neurol 22:1308-1311.
17. Fido A, Al-Saad S. 2005. Toxic trace elements in the hair of children with autism. Autism 9:290-298.
18. Gallagher C, Goodman M. 2008. Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years. Toxicol Environ Chem 90:997-1008.
19. Gbor PK, Wen D, Meng F, Yang F, Zhang B, Sloan JJ. 2006. Improved model for mercury emission transport and deposition. Atmos Environ 40:973-983.
20. Geier DA, Geier MR. 2006. A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox Res 10:57-64.
21. Geier DA, Geier MR. 2007a. A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health, Part A 70:1723-1730.
22. Geier DA, Geier MR. 2007b. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders. J Toxicol Environ Health, Part A 70:837-851.
23. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR. 2008a. Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci. Sept 24. doi:10.1016/j. jns.2008.08.021.
24. Geier DA, Mumper E, Gadfelter B, Coleman L, Geier MR. 2008b. Neurodevelopmental disorders, maternal Rh-negativity, and Rho (D) immune globulins: a multi-center assessment. Neuroendocrinol Lett 29:272-280
25. Haase H, Hebel S, Engelhardt G, Rink L. 2008. Zinc ions cause the thimerosal-induced signal of fluorescent calcium probes in lymphocytes. Cell Calcium Oct 31 [Epub ahead of print].
26. Herbein G, Varin A, Fulop T. 2006. NF-?B, AP-1, zinc-deficiency and aging. Biogerontology 7:409-419.
27. Heuchel R, Radtke F, Georgiev O, Stark G, Aguet M, Schaffner W.1994. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J 13:2870-2875.
28. Hidalgo J, Aschner M, Zatta P, Vasak M. 2001. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 55:133-145.
29. Holmes AS, Blaxill MF, Haley BE. 2003. Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 22:277-285.
30. Institute of Medicine (IOM). 2004. Vaccines and autism. Immunization safety review committee. Washington, DC: National Academy Press.
31. Jenkins SL, Kelleher S, McKnight R, Calloway CW, Yu X, Want L, Lonnerdal B, Lane RH. 2004. Lymphocyte differences and zinc deficiency secondary to intrauterine growth restriction [Abstract]. Pediatr Res Abstract Issue 55:181A.
32. Kirby D. 2005. Evidence of Harm. New York: St. Martin's Press.
33. Knight SAB, Koch KA, Thiele, DJ. 1998. Yeast metallothionein gene regulation. In: Silver S, Walden W, eds. Metal Ions in Gene Regulation. New York: International Thomson Publishing. p. 316-341.
34. Lathe R. 2006. Autism, Brain and Environment. London: Jessica Kingsley Publishers.
35. Leary SC, Winge DR, Cobine PA. 2009. 'Pulling the plug' on cellular copper: the role of mitochondria in copper export. Biochim Biophys Acta 1793:146-153.
36. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M. 2000. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30:205-223.
37. Myles BS, Bock SJ, Simpson RL. 2001. Asperger Syndrome Diagnostic Scale. Austin, TX: PRO-ED Inc.
38. Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R. 2006. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Appl Pharmacol 214:99-108.
39. Ozdemir E, Cetinkaya S, Ersan S, Kucukosman S, Ersan EE. 2008. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 2009; 33(1):62-65.
40. Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C. 2006. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 12:203-209.
41. Palmer RF, Blanchard S, Wood R. 2009. Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 15:18-24.
42. Park JD, Liu Y, Klaassen CD. 2001. Protective effect of metallothionein against the toxicity of cadmium and other metals. Toxicology 163:93-100.
43. Roelofsen H, Balgobind R, Vonk RJ. 2004. Proteomic analyses of copper metabolism in an in vitro model of Wilson Disease using surface enhanced laser desorption/ionization-time of flightmass spectrometry. J Cell Biochem 93:732-740.
44. Rosenzweig AC. 2001. Copper delivery by metallochaperone proteins. Account Chem Res 34:119-128.
45. Schopler E, Reichler RJ, Rochen Renner B. 1988. The Childhood Autism Rating Scale (CARS). Los Angeles, CA: Western Psychological Services.
46. Schubert J. 1964. Copper and Peroxides in Radiobiology and Medicine. Springfield, IL: Charles C. Thomas Publisher.
47. Serajee FJ, Nabi R, Zhong H, Huq AHMM. 2004. Polymorphisms in xenobiotic metabolism genes and autism. J Child Neurol 19:413-417.
48. Shankar AH, Prasad AS. 1998. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 68:447S-463S.
49. Sprietsma JE. 1999. Cysteine, glutathione (GSH) and zinc and copper ions together are effective, natural, intracellular inhibitors of (AIDS) viruses. Med Hypoth 52:529-538.
50. Takeda A, Sakurada N, Kanno S, Minami A, Oku N. 2006. Response of extracellular zinc in the ventral hippocampus against novelty stress. J Neurochem 99:670-676.
51. Turnlund JR. 1998. Human whole-body copper metabolism. Am J Clin Nutr 67(Suppl.):960S-964S.
52. Van Weyenbergh J, Santana G, D'Oliveira A Jr, Santos AF Jr, Costa CH, Carvalho EM, Barral A, Barral-Netto M. 2004. Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: and ex vivo and in vitro study. BMC Infect Dis 4:50.
53. Walker CF, Black RE. 2004. Zinc and the risk for infectious disease. Annu Rev Nutr 24:255-275.
54. Walker SJ, Segal J, Aschner M. 2006. Cultured lymphocytes from autistic children and non-autistic siblings up-regulate heat shock protein RNA in response to thiomerosal challenge. Neurotoxicology 27:685-692.
55. Walsh WJ, Isaacson HR, Rehman F, Hall A. 1997. Elevated blood copper/zinc ratios in assaultive young males. Physiol Behav 62:327-329.
56. Walsh WJ, Usman A, Tarpey J. 2001. Disordered metal metabolism in a large autism population. Proceedings of the American Psychiatric Association Conference. New Orleans, May 5-10. Available from: *http://www.hriptc.org/ metal-autism.html.
57. Walsh WJ, Usman A, Tarpey J, Kelly T. 2002. Metallothionein and Autism [Monograph], 2nd edn. Naperville, IL: Health Research Institute Pfieffer Treatment Center.
58. Wang Y, Wimmer U, Lichtlen P, Inderbitzin D, Stieger B, Meier PJ, Hunziker L, Stallmach T, Forrer R, Rulicke T, Georgiev O, Schaffner W. 2004. Metal-responsive transcription factor- 1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liver. FASEB J 18:1071-1079.
59. Wimmer U, Wang Y, Georgiev O, Schaffner W. 2005. Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione. Nucl Acids Res 33:5715-5727.
60. Windham GC, Zhang L, Gunier R, Croen L, Grether JK. 2006. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Franciso Bay area. Environ Health Perspect 114:1438-1444
61. Young HA, Geier DA, Geier MR. 2008. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 271:110-118.